Yu EY, Piulats JM, Gravis G, Fong PCC, et al. Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study. Eur Urol 2022 Aug 30. pii: S0302-2838(22)02554.
PMID: 36055895